Merck & Co., Inc. XLO Holdings History
Number of Shares
1.48 Mil
Current Holdings Value*
$1.07 Mil
% of Portfolio
0.65%
Total Estimate Gain
$-379,693.67
% of Total Estimate Gain
-25.85%
Merck & Co., Inc.'s Xilio Therapeutics Inc Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 1.48 Mil shares of Xilio Therapeutics Inc(XLO), totaling $1.07 Mil. This investment constitutes 0.65% of their stock portfolio, and Merck & Co., Inc. now holds 2.87% of the outstanding Xilio Therapeutics Inc(XLO) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and XLO's current price of $0.73, Merck & Co., Inc.'s estimated gain on his XLO holdings is $-379,693.67, reflecting a -25.85% gain to date.
Merck & Co., Inc. XLO ($0.73) Holding Chart
Merck & Co., Inc. XLO ($0.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers